| Product Code: ETC8854767 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Whole exome sequencing is more affordable than full genome sequencing and is commonly used in genetic diagnostics. Growth is driven by healthcare providers integrating it into services for diagnosing complex conditions, especially in pediatric and neurological cases.
In the Philippines, whole exome sequencing (WES) is finding growing application in medical diagnostics, particularly for detecting rare and hereditary diseases. It is preferred over WGS in many clinical settings due to its reduced cost and focus on protein-coding regions. Expansion is supported by partnerships between local diagnostic labs and international genomic firms, and by the push toward personalized healthcare.
Whole exome sequencing market challenges include limited funding for genomic medicine and a scarcity of clinical programs adopting sequencing for diagnosis. Data management and interpretation require sophisticated infrastructure, which is often lacking. Public understanding and acceptance remain low, reducing demand from patients and providers.
Whole exome sequencing focuses on the coding regions of the genome, offering cost-effective genetic insights. Investments in affordable sequencing services and bioinformatics support cater to clinical genetics, pharmacogenomics, and personalized medicine demands. Partnerships with healthcare providers and research organizations can accelerate market growth.
The whole exome sequencing market aligns with national policies regulating genetic testing, emphasizing data privacy and ethical research. The DOH promotes clinical applications for genetic disorders while the DOST funds scientific advancements in genomics.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Whole Exome Sequencing Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Whole Exome Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Whole Exome Sequencing Market - Industry Life Cycle |
3.4 Philippines Whole Exome Sequencing Market - Porter's Five Forces |
3.5 Philippines Whole Exome Sequencing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Whole Exome Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Whole Exome Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare in the Philippines |
4.2.2 Growing prevalence of genetic disorders and diseases in the population |
4.2.3 Technological advancements in whole exome sequencing leading to cost reductions and improved efficiency |
4.3 Market Restraints |
4.3.1 Lack of awareness and understanding of whole exome sequencing among healthcare professionals and patients |
4.3.2 Limited infrastructure and resources for genetic testing and sequencing in the Philippines |
4.3.3 Regulatory challenges and ethical considerations surrounding genetic testing and data privacy |
5 Philippines Whole Exome Sequencing Market Trends |
6 Philippines Whole Exome Sequencing Market, By Types |
6.1 Philippines Whole Exome Sequencing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Whole Exome Sequencing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Whole Exome Sequencing Market Revenues & Volume, By Agilent HaloPlex, 2021- 2031F |
6.1.4 Philippines Whole Exome Sequencing Market Revenues & Volume, By Agilent SureSelect, 2021- 2031F |
6.1.5 Philippines Whole Exome Sequencing Market Revenues & Volume, By Agilent SureSelect QXT, 2021- 2031F |
6.1.6 Philippines Whole Exome Sequencing Market Revenues & Volume, By Illumina TruSeq Exome, 2021- 2031F |
6.1.7 Philippines Whole Exome Sequencing Market Revenues & Volume, By Roche Nimblegen SeqCap, 2021- 2031F |
6.1.8 Philippines Whole Exome Sequencing Market Revenues & Volume, By MYcroarray MYbaits, 2021- 2031F |
6.2 Philippines Whole Exome Sequencing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Whole Exome Sequencing Market Revenues & Volume, By Correlation Research of Normal Human, 2021- 2031F |
6.2.3 Philippines Whole Exome Sequencing Market Revenues & Volume, By Mendelian Disease and Rare Syndrome Gene Discovery, 2021- 2031F |
6.2.4 Philippines Whole Exome Sequencing Market Revenues & Volume, By The Research of Complex Diseases, 2021- 2031F |
6.2.5 Philippines Whole Exome Sequencing Market Revenues & Volume, By Mouse Exome Sequencing, 2021- 2031F |
7 Philippines Whole Exome Sequencing Market Import-Export Trade Statistics |
7.1 Philippines Whole Exome Sequencing Market Export to Major Countries |
7.2 Philippines Whole Exome Sequencing Market Imports from Major Countries |
8 Philippines Whole Exome Sequencing Market Key Performance Indicators |
8.1 Adoption rate of whole exome sequencing in clinical settings |
8.2 Number of research studies and collaborations involving whole exome sequencing in the Philippines |
8.3 Rate of increase in genetic testing reimbursement by healthcare insurance providers |
9 Philippines Whole Exome Sequencing Market - Opportunity Assessment |
9.1 Philippines Whole Exome Sequencing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Whole Exome Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Whole Exome Sequencing Market - Competitive Landscape |
10.1 Philippines Whole Exome Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Philippines Whole Exome Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |